Joanne Wuensch
Stock Analyst at Citigroup
(4.38)
# 280
Out of 4,870 analysts
384
Total ratings
62.16%
Success rate
11.94%
Average return
Main Sectors:
Stocks Rated by Joanne Wuensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Maintains: Neutral | $20 → $24 | $20.22 | +18.69% | 15 | May 22, 2025 | |
| SYK Stryker | Maintains: Buy | $443 → $455 | $379.16 | +20.00% | 14 | May 22, 2025 | |
| SGHT Sight Sciences | Maintains: Neutral | $3.2 → $3.6 | $4.34 | -17.05% | 11 | May 22, 2025 | |
| LUNG Pulmonx | Maintains: Neutral | $6.5 → $4.15 | $2.57 | +61.48% | 11 | May 22, 2025 | |
| IRTC iRhythm Technologies | Maintains: Buy | $130 → $167 | $150.95 | +10.63% | 18 | May 22, 2025 | |
| ISRG Intuitive Surgical | Maintains: Buy | $590 → $650 | $515.09 | +26.19% | 17 | May 22, 2025 | |
| PODD Insulet | Maintains: Buy | $320 → $380 | $307.67 | +23.51% | 15 | May 22, 2025 | |
| EW Edwards Lifesciences | Maintains: Buy | $84 → $95 | $75.32 | +26.13% | 20 | May 22, 2025 | |
| DXCM DexCom | Maintains: Buy | $82 → $102 | $79.84 | +27.76% | 14 | May 22, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $119 → $125 | $102.36 | +22.12% | 35 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $133 → $140 | $119.07 | +17.58% | 5 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $13 | $12.00 | +8.33% | 5 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $105 → $86 | $71.16 | +20.85% | 4 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $110 | $69.52 | +58.23% | 20 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $160 | $133.26 | +20.07% | 20 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $92 → $107 | $85.96 | +24.48% | 19 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $200 → $245 | $254.46 | -3.72% | 24 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $175 | $151.32 | +15.65% | 12 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $37 → $35 | $29.99 | +16.71% | 20 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $132 → $162 | $96.80 | +67.36% | 20 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $16 → $22 | $11.62 | +89.33% | 14 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $45 → $50 | $36.70 | +36.24% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $94 → $85 | $72.07 | +17.94% | 7 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $134 → $120 | $91.50 | +31.15% | 22 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $220 → $250 | $169.72 | +47.30% | 5 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $67 → $69 | $85.35 | -19.16% | 5 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $109 → $127 | $254.52 | -50.10% | 6 | Dec 10, 2018 |
Tandem Diabetes Care
May 22, 2025
Maintains: Neutral
Price Target: $20 → $24
Current: $20.22
Upside: +18.69%
Stryker
May 22, 2025
Maintains: Buy
Price Target: $443 → $455
Current: $379.16
Upside: +20.00%
Sight Sciences
May 22, 2025
Maintains: Neutral
Price Target: $3.2 → $3.6
Current: $4.34
Upside: -17.05%
Pulmonx
May 22, 2025
Maintains: Neutral
Price Target: $6.5 → $4.15
Current: $2.57
Upside: +61.48%
iRhythm Technologies
May 22, 2025
Maintains: Buy
Price Target: $130 → $167
Current: $150.95
Upside: +10.63%
Intuitive Surgical
May 22, 2025
Maintains: Buy
Price Target: $590 → $650
Current: $515.09
Upside: +26.19%
Insulet
May 22, 2025
Maintains: Buy
Price Target: $320 → $380
Current: $307.67
Upside: +23.51%
Edwards Lifesciences
May 22, 2025
Maintains: Buy
Price Target: $84 → $95
Current: $75.32
Upside: +26.13%
DexCom
May 22, 2025
Maintains: Buy
Price Target: $82 → $102
Current: $79.84
Upside: +27.76%
Boston Scientific
May 22, 2025
Maintains: Buy
Price Target: $119 → $125
Current: $102.36
Upside: +22.12%
May 22, 2025
Upgrades: Buy
Price Target: $133 → $140
Current: $119.07
Upside: +17.58%
May 1, 2025
Maintains: Neutral
Price Target: $14 → $13
Current: $12.00
Upside: +8.33%
Apr 30, 2025
Maintains: Buy
Price Target: $105 → $86
Current: $71.16
Upside: +20.85%
Mar 7, 2025
Maintains: Buy
Price Target: $115 → $110
Current: $69.52
Upside: +58.23%
Mar 4, 2025
Maintains: Buy
Price Target: $135 → $160
Current: $133.26
Upside: +20.07%
Mar 4, 2025
Upgrades: Buy
Price Target: $92 → $107
Current: $85.96
Upside: +24.48%
Dec 11, 2024
Maintains: Neutral
Price Target: $200 → $245
Current: $254.46
Upside: -3.72%
Dec 11, 2024
Maintains: Buy
Price Target: $185 → $175
Current: $151.32
Upside: +15.65%
Dec 11, 2024
Maintains: Neutral
Price Target: $37 → $35
Current: $29.99
Upside: +16.71%
Dec 11, 2024
Upgrades: Buy
Price Target: $132 → $162
Current: $96.80
Upside: +67.36%
Nov 5, 2024
Maintains: Sell
Price Target: $16 → $22
Current: $11.62
Upside: +89.33%
Oct 1, 2024
Maintains: Neutral
Price Target: $45 → $50
Current: $36.70
Upside: +36.24%
Aug 22, 2024
Maintains: Neutral
Price Target: $94 → $85
Current: $72.07
Upside: +17.94%
Jul 10, 2024
Maintains: Neutral
Price Target: $134 → $120
Current: $91.50
Upside: +31.15%
Dec 12, 2022
Upgrades: Neutral
Price Target: $220 → $250
Current: $169.72
Upside: +47.30%
Nov 17, 2022
Maintains: Neutral
Price Target: $67 → $69
Current: $85.35
Upside: -19.16%
Dec 10, 2018
Upgrades: Outperform
Price Target: $109 → $127
Current: $254.52
Upside: -50.10%